BeOne Medicines Ltd. — Director's Dealing 2018

Feb 1, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2018-01-22

Reporting Person: Hillhouse Capital Management, Ltd. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	71139367	Indirect

Footnotes

F1: Consists of (i) 4,142,600 ADSs, representing 53,853,800 Ordinary Shares, held by Gaoling Fund, L.P., an exempted Cayman Islands limited partnership ("Gaoling"), (ii) 295,353 ADSs, representing 3,839,589 Ordinary Shares, held by YHG Investment, L.P., an exempted Cayman Islands limited partnership ("YHG"), and (iii) 1,034,306 ADSs, representing 13,445,978 Ordinary Shares held by Hillhouse BGN Holdings Limited, an exempted Cayman Islands company ("BGN").

F2: The securities to which this filing relates are held directly by BGN, YHG, and Gaoling. BGN is owned by Hillhouse Fund II, L.P., an exempted Cayman Islands limited partnership. Hillhouse Capital Management, Ltd., an exempted Cayman Islands company ("Hillhouse Capital" or the "Reporting Person"), acts as the sole management company of Hillhouse Fund II, L.P. Hillhouse Capital also acts as the sole general partner of YHG and the sole management company of Gaoling. Mr. Lei Zhang may be deemed to have controlling power over Hillhouse Capital. Mr. Lei Zhang disclaims beneficial ownership of all of the shares held by BGN, YHG and Gaoling except to the extent of his pecuniary interest therein.

F3: The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.